BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schaad U, Wedgwood-krucko J, Tschaeppeler H. REVERSIBLE CEFTRIAXONE-ASSOCIATED BILIARY PSEUDOLITHIASIS IN CHILDREN. The Lancet 1988;332:1411-3. [DOI: 10.1016/s0140-6736(88)90596-x] [Cited by in Crossref: 152] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Stojanovic V, Djuric Vijatov G. Nephrolithiasis caused by ceftriaxone in a 3-year-old child with ureteropelvic junction obstruction. Case Rep Med 2009;2009:365962. [PMID: 19718430 DOI: 10.1155/2009/365962] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
2 Imafuku A, Sawa N, Sekine A, Kawada M, Hiramatsu R, Yamanouchi M, Hasegawa E, Hayami N, Hoshino J, Ubara Y, Takaichi K. Risk factors of ceftriaxone-associated biliary pseudolithiasis in adults: influence of renal dysfunction. Clin Exp Nephrol 2018;22:613-9. [PMID: 29027036 DOI: 10.1007/s10157-017-1493-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
3 Azarkar G, Birjand MM, Ehsanbakhsh A, Bijari B, Abedini MR, Ziaee M. Ceftriaxone-associated nephrolithiasis and gallstone in adults. Drug Healthc Patient Saf 2018;10:103-8. [PMID: 30588126 DOI: 10.2147/DHPS.S183892] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Hofmann AF. Current concepts of biliary secretion. Dig Dis Sci 1989;34:16S-20S. [PMID: 2689114 DOI: 10.1007/BF01536657] [Cited by in Crossref: 33] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
5 Bartkowska-Śniatkowska A, Jończyk-Potoczna K, Zielińska M, Rosada-Kurasińska J. Adverse reaction to ceftriaxone in a 28-day-old infant undergoing urgent craniotomy due to epidural hematoma: review of neonatal biliary pseudolithiasis. Ther Clin Risk Manag 2015;11:1035-41. [PMID: 26170682 DOI: 10.2147/TCRM.S79419] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
6 Nau R, Sörgel F, Prange HW. Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections. Clin Pharmacokinet 1998;35:223-46. [PMID: 9784935 DOI: 10.2165/00003088-199835030-00005] [Cited by in Crossref: 67] [Cited by in F6Publishing: 50] [Article Influence: 2.9] [Reference Citation Analysis]
7 Kimata T, Kaneko K, Takahashi M, Hirabayashi M, Shimo T, Kino M. Increased urinary calcium excretion caused by ceftriaxone: possible association with urolithiasis. Pediatr Nephrol 2012;27:605-9. [PMID: 22038204 DOI: 10.1007/s00467-011-2038-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
8 Choi YY, Jung YH, Choi SM, Lee CS, Kim D, Hur KY. Gallbladder pseudolithiasis caused by ceftriaxone in young adult. J Korean Surg Soc 2011;81:423-6. [PMID: 22200045 DOI: 10.4174/jkss.2011.81.6.423] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Fretzayas A, Liapi O, Papadopoulou A, Nicolaidou P, Stamoulakatou A. Is Ceftriaxone-Induced Biliary Pseudolithiasis Influenced by UDP-Glucuronosyltransferase 1A1 Gene Polymorphisms? Case Rep Med 2011;2011:730250. [PMID: 22110515 DOI: 10.1155/2011/730250] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
10 Simonsen KA, Anderson-Berry AL, Delair SF, Davies HD. Early-onset neonatal sepsis. Clin Microbiol Rev. 2014;27:21-47. [PMID: 24396135 DOI: 10.1128/cmr.00031-13] [Cited by in Crossref: 362] [Cited by in F6Publishing: 157] [Article Influence: 51.7] [Reference Citation Analysis]
11 Lamb HM, Ormrod D, Scott LJ, Figgitt DP. Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections. Drugs 2002;62:1041-89. [PMID: 11985490 DOI: 10.2165/00003495-200262070-00005] [Cited by in Crossref: 72] [Cited by in F6Publishing: 55] [Article Influence: 3.8] [Reference Citation Analysis]
12 Martínez-Lage JF, Girón Vallejo O, López López-Guerrero A, Martínez-Lage Azorín L, Roqués JL, Almagro MJ. Acute cholecystitis complicating ventriculo-peritoneal shunting: report of a case and review of the literature. Childs Nerv Syst 2008;24:777-9. [PMID: 18365208 DOI: 10.1007/s00381-008-0617-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Michielsen PP, Fierens H, Van Maercke YM. Drug-induced gallbladder disease. Incidence, aetiology and management. Drug Saf 1992;7:32-45. [PMID: 1536697 DOI: 10.2165/00002018-199207010-00005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
14 Kutuya N, Ozaki Y, Okazaki T. A symptomatic child with ceftriaxone-associated biliary pseudolithiasis. J Med Ultrason (2001) 2008;35:125-8. [PMID: 27278835 DOI: 10.1007/s10396-008-0170-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
15 Cryan B, Wright DJ. Lyme disease in paediatrics. Arch Dis Child 1991;66:1359-63. [PMID: 1755656 DOI: 10.1136/adc.66.11.1359] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
16 Daudon M, Frochot V, Bazin D, Jungers P. Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment. Drugs 2018;78:163-201. [PMID: 29264783 DOI: 10.1007/s40265-017-0853-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 16] [Article Influence: 20.5] [Reference Citation Analysis]
17 Heim-Duthoy KL, Caperton EM, Pollock R, Matzke GR, Enthoven D, Peterson PK. Apparent biliary pseudolithiasis during ceftriaxone therapy. Antimicrob Agents Chemother 1990;34:1146-9. [PMID: 2203305 DOI: 10.1128/AAC.34.6.1146] [Cited by in Crossref: 63] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
18 Kajiwara T, Ariga H, Kashimura J. Ceftriaxone pseudolithiasis detected by computed tomography and followed up until resolution. J Rural Med 2020;15:230-3. [PMID: 33033548 DOI: 10.2185/jrm.2020-020] [Reference Citation Analysis]
19 Avci Z, Koktener A, Uras N, Catal F, Karadag A, Tekin O, Degirmencioglu H, Baskin E. Nephrolithiasis associated with ceftriaxone therapy: a prospective study in 51 children. Arch Dis Child 2004;89:1069-72. [PMID: 15499067 DOI: 10.1136/adc.2003.044156] [Cited by in Crossref: 53] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
20 Hung WY, Abreu Lanfranco O. Contemporary review of drug-induced pancreatitis: A different perspective. World J Gastrointest Pathophysiol. 2014;5:405-415. [PMID: 25400984 DOI: 10.4291/wjgp.v5.i4.405] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 29] [Article Influence: 7.1] [Reference Citation Analysis]
21 Spencer S, Ipema H, Hartke P, Krueger C, Rodriguez R, Gross AE, Gabay M. Intravenous Push Administration of Antibiotics: Literature and Considerations. Hosp Pharm 2018;53:157-69. [PMID: 30147136 DOI: 10.1177/0018578718760257] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 4.7] [Reference Citation Analysis]
22 Zaki SA, Shanbag P. Biliary pseudolithiasis secondary to ceftriaxone therapy. Indian J Pharmacol 2010;42:193-4. [PMID: 20871775 DOI: 10.4103/0253-7613.66847] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]